These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 25061277)

  • 1. Clinical effectiveness and safety of montelukast in asthma. What are the conclusions from clinical trials and meta-analyses?
    Hon KL; Leung TF; Leung AK
    Drug Des Devel Ther; 2014; 8():839-50. PubMed ID: 25061277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A subgroup analysis of the MONICA study: a 12-month, open-label study of add-on montelukast treatment in asthma patients.
    Virchow JC; Mehta A; Ljungblad L; Mitfessel H
    J Asthma; 2010 Nov; 47(9):986-93. PubMed ID: 20858152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Review of recent results of montelukast use as a monotherapy in children with mild asthma.
    Wahn U; Dass SB
    Clin Ther; 2008; 30 Spec No():1026-35. PubMed ID: 18640477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Daily inhaled corticosteroids or montelukast for preschoolers with asthma or recurrent wheezing: A systematic review.
    Castro-Rodriguez JA; Rodriguez-Martinez CE; Ducharme FM
    Pediatr Pulmonol; 2018 Dec; 53(12):1670-1677. PubMed ID: 30394700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Montelukast, a leukotriene receptor antagonist, for the treatment of persistent asthma in children aged 2 to 5 years.
    Knorr B; Franchi LM; Bisgaard H; Vermeulen JH; LeSouef P; Santanello N; Michele TM; Reiss TF; Nguyen HH; Bratton DL
    Pediatrics; 2001 Sep; 108(3):E48. PubMed ID: 11533366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of inhaled corticosteroids and montelukast in children with mild-moderate asthma: results of a systematic review with meta-analysis.
    Castro-Rodriguez JA; Rodrigo GJ
    Arch Dis Child; 2010 May; 95(5):365-70. PubMed ID: 19946008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of within-subject responses to fluticasone and montelukast in childhood asthma.
    Szefler SJ; Phillips BR; Martinez FD; Chinchilli VM; Lemanske RF; Strunk RC; Zeiger RS; Larsen G; Spahn JD; Bacharier LB; Bloomberg GR; Guilbert TW; Heldt G; Morgan WJ; Moss MH; Sorkness CA; Taussig LM
    J Allergy Clin Immunol; 2005 Feb; 115(2):233-42. PubMed ID: 15696076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Montelukast in the treatment of mild to moderate persistent asthma].
    Bellecoste V; Devouassoux G; Pacheco Y
    Rev Mal Respir; 2011 Jun; 28(6):706-29. PubMed ID: 21742233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Montelukast: data from clinical trials in the management of asthma.
    Blake KV
    Ann Pharmacother; 1999 Dec; 33(12):1299-314. PubMed ID: 10630831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Montelukast for prevention and treatment of asthma exacerbations in adults: Systematic review and meta-analysis.
    Zhang HP; Jia CE; Lv Y; Gibson PG; Wang G
    Allergy Asthma Proc; 2014; 35(4):278-87. PubMed ID: 24992547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inflammatory markers as exacerbation risk factors after asthma therapy switch from inhaled steroids to montelukast.
    Ciółkowski J; Mazurek H; Hydzik P; Stasiowska B
    Pulm Pharmacol Ther; 2016 Aug; 39():7-13. PubMed ID: 27234706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative study of budesonide inhalation suspension and montelukast in young children with mild persistent asthma.
    Szefler SJ; Baker JW; Uryniak T; Goldman M; Silkoff PE
    J Allergy Clin Immunol; 2007 Nov; 120(5):1043-50. PubMed ID: 17983871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spotlight on montelukast in asthma in children 2 to 14 years of age.
    Muijsers RB; Noble S
    Am J Respir Med; 2002; 1(3):225-8. PubMed ID: 14720060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Montelukast added to budesonide in children with persistent asthma: a randomized, double-blind, crossover study.
    Simons FE; Villa JR; Lee BW; Teper AM; Lyttle B; Aristizabal G; Laessig W; Schuster A; Perez-Frias J; Sekerel BE; Menten J; Leff JA
    J Pediatr; 2001 May; 138(5):694-8. PubMed ID: 11343045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhaled corticosteroids or montelukast as the preferred primary long-term treatment for pediatric asthma?
    Jartti T
    Eur J Pediatr; 2008 Jul; 167(7):731-6. PubMed ID: 18214538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Montelukast in childhood asthma.
    Mehta PN
    Indian Pediatr; 2000 Nov; 37(11):1201-9. PubMed ID: 11086302
    [No Abstract]   [Full Text] [Related]  

  • 17. Roflumilast combined with montelukast versus montelukast alone as add-on treatment in patients with moderate-to-severe asthma.
    Bateman ED; Goehring UM; Richard F; Watz H
    J Allergy Clin Immunol; 2016 Jul; 138(1):142-149.e8. PubMed ID: 26915674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leukotriene-receptor antagonists.
    Lipworth BJ
    Lancet; 1999 Jan; 353(9146):57-62. PubMed ID: 10023966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral montelukast versus inhaled beclomethasone in 6- to 11-year-old children with asthma: results of an open-label extension study evaluating long-term safety, satisfaction, and adherence with therapy.
    Maspero JF; Dueñas-Meza E; Volovitz B; Pinacho Daza C; Kosa L; Vrijens F; Leff JA
    Curr Med Res Opin; 2001; 17(2):96-104. PubMed ID: 11759189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and tolerability of salmeterol/fluticasone propionate versus montelukast in childhood asthma: A prospective, randomized, double-blind, double-dummy, parallel-group study.
    Maspero J; Guerra F; Cuevas F; Gutierrez JP; Soto-Ramos M; Anderton S; Mechali D; Chan R; Pedersen S
    Clin Ther; 2008 Aug; 30(8):1492-504. PubMed ID: 18803991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.